Disease and Therapy Review: Cervical Cancer

Timely Data Resources, Inc, February 2012, Pages: 14

Disease and Therapy Reviews were developed to provide a basic understanding of the key facts about a disease and market in a quick, easy-to-read format.  These reports are prepared by the senior market research team of Timely Data Resources.  Each Disease and Therapy Review provides a concise analysis of the most important information about a particular disease, its treatment, and the market opportunities. 

Reports begin with an overview of the condition, and also contain tables that summarize the available worldwide incidence and prevalence data for the condition, a review of current diagnosis strategies and treatment options, general information about the market size, and information about important market trends.  The data contained in these reports comes from key industry secondary data sources, such as the Timely Data Resources Incidence and Prevalence Database, and Lange's Current Medical Diagnosis and Treatment.  This information is supplemented by reviews of analyst reports, company reports, and medical websites.  Sources and references are provided.  

The Cervical Cancer Disease and Therapy Review provides an overview of the disease and related conditions, with incidence, prevalence, and mortality numbers for major countries worldwide, information on diagnosis, and an overview of treatment. Dosing and treatment cost information is provided for various treatment types. General information on the cervical cancer market, as well as sales of leading drugs and therapies are provided.

I. OVERVIEW
General overview of the condition
Types of cervical cancer
Symptoms and signs
Risk factors
Staging

II. INCIDENCE, PREVALENCE AND MORTALITY
Incidence Table (Canada, U.S., Argentina, Brazil, Mexico, France, Germany, Greece, Italy, Poland, Russian Federation, Spain, Sweden, Turkey, UK, China, India, Indonesia, Japan, Philippines, Taiwan, Thailand, Egypt, South Africa, Africa, Americas, Eastern Mediterranean, Europe, Southeast Asia, Western Pacific, Worldwide)
Prevalence Table (Canada, U.S., Mexico, France, Germany, Italy, Spain, UK, China, India, Japan, Worldwide)
Mortality Table (Canada, U.S., Argentina, Brazil, Mexico, France, Germany, Greece, Italy, Poland, Russian Federation, Spain, Sweden, Turkey, UK, China, India, Indonesia, Japan, Philippines, Taiwan, Thailand, Vietnam, Egypt, South Africa, Africa, Americas, Eastern Mediterranean, Europe, Southeast Asia, Western Pacific, Worldwide)
Survival rates by stage

III. DIAGNOSIS
Screening
Diagnostic tools and procedure

IV. TREAMENT
Prevention
Emergency treatment
Treatment by stage

V. TREATMENT COSTS
Overview of costs for common treatments

VI. MARKET SIZE
Overall market size
Sales information for key pharmaceuticals

VII. COMMENTS

VIII. REFERENCES/RESOURCES

Product Samples

A sample for this product is available. Please Login/Register to download this sample.

Customers who bought this item also bought

• Global Biosimilars Market - Products, Applications and Regulations
• Global Pancreatic Cancer Epidemiology and Patient Flow Analysis - 2012
• Active Pharmaceutical Ingredients (API) Market in Europe to 2017 - Pricing and Reimbursement Initiatives Supporting Generic Drug Growth, with CMOs Expected to Account for Majority of the Manufacturing Activity
• Industrial Pharmaceutical Microbiology: Standards & Controls
• Europe Vitamin and Dietary Supplements Demand and Forecast
• Global Type 1 Diabetes Epidemiology and Patient Flow Analysis - 2012
• Global Prostate Cancer Epidemiology and Patient Flow Analysis - 2012
• Global Overactive Bladder Epidemiology and Patient Flow Analysis - 2012
• Global Diabetic Retinopathy Epidemiology and Patient Flow Analysis - 2012
• Global Ulcerative Colitis Epidemiology and Patient Flow Analysis - 2012